Chapter/Section Purchase

1 Study Coverage
1.1 Human Somatotropin Product Introduction
1.2 Market by Type
1.2.1 Global Human Somatotropin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Powder
1.2.3 Solvent
1.3 Market by Application
1.3.1 Global Human Somatotropin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Somatotropin Sales Estimates and Forecasts 2017-2028
2.2 Global Human Somatotropin Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Somatotropin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Somatotropin Sales by Region
2.4.1 Global Human Somatotropin Sales by Region (2017-2022)
2.4.2 Global Sales Human Somatotropin by Region (2023-2028)
2.5 Global Human Somatotropin Revenue by Region
2.5.1 Global Human Somatotropin Revenue by Region (2017-2022)
2.5.2 Global Human Somatotropin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Somatotropin Sales by Manufacturers
3.1.1 Global Top Human Somatotropin Manufacturers by Sales (2017-2022)
3.1.2 Global Human Somatotropin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Somatotropin in 2021
3.2 Global Human Somatotropin Revenue by Manufacturers
3.2.1 Global Human Somatotropin Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Somatotropin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Somatotropin Revenue in 2021
3.3 Global Human Somatotropin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Somatotropin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Somatotropin Sales by Type
4.1.1 Global Human Somatotropin Historical Sales by Type (2017-2022)
4.1.2 Global Human Somatotropin Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Somatotropin Sales Market Share by Type (2017-2028)
4.2 Global Human Somatotropin Revenue by Type
4.2.1 Global Human Somatotropin Historical Revenue by Type (2017-2022)
4.2.2 Global Human Somatotropin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Somatotropin Revenue Market Share by Type (2017-2028)
4.3 Global Human Somatotropin Price by Type
4.3.1 Global Human Somatotropin Price by Type (2017-2022)
4.3.2 Global Human Somatotropin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Somatotropin Sales by Application
5.1.1 Global Human Somatotropin Historical Sales by Application (2017-2022)
5.1.2 Global Human Somatotropin Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Somatotropin Sales Market Share by Application (2017-2028)
5.2 Global Human Somatotropin Revenue by Application
5.2.1 Global Human Somatotropin Historical Revenue by Application (2017-2022)
5.2.2 Global Human Somatotropin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Somatotropin Revenue Market Share by Application (2017-2028)
5.3 Global Human Somatotropin Price by Application
5.3.1 Global Human Somatotropin Price by Application (2017-2022)
5.3.2 Global Human Somatotropin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Somatotropin Market Size by Type
6.1.1 North America Human Somatotropin Sales by Type (2017-2028)
6.1.2 North America Human Somatotropin Revenue by Type (2017-2028)
6.2 North America Human Somatotropin Market Size by Application
6.2.1 North America Human Somatotropin Sales by Application (2017-2028)
6.2.2 North America Human Somatotropin Revenue by Application (2017-2028)
6.3 North America Human Somatotropin Market Size by Country
6.3.1 North America Human Somatotropin Sales by Country (2017-2028)
6.3.2 North America Human Somatotropin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
7 Europe
7.1 Europe Human Somatotropin Market Size by Type
7.1.1 Europe Human Somatotropin Sales by Type (2017-2028)
7.1.2 Europe Human Somatotropin Revenue by Type (2017-2028)
7.2 Europe Human Somatotropin Market Size by Application
7.2.1 Europe Human Somatotropin Sales by Application (2017-2028)
7.2.2 Europe Human Somatotropin Revenue by Application (2017-2028)
7.3 Europe Human Somatotropin Market Size by Country
7.3.1 Europe Human Somatotropin Sales by Country (2017-2028)
7.3.2 Europe Human Somatotropin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Somatotropin Market Size by Type
8.1.1 Asia Pacific Human Somatotropin Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Somatotropin Revenue by Type (2017-2028)
8.2 Asia Pacific Human Somatotropin Market Size by Application
8.2.1 Asia Pacific Human Somatotropin Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Somatotropin Revenue by Application (2017-2028)
8.3 Asia Pacific Human Somatotropin Market Size by Region
8.3.1 Asia Pacific Human Somatotropin Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Somatotropin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Indonesia
8.3.9 Thailand
8.3.10 Malaysia
8.3.11 Philippines
8.3.12 Vietnam
9 Latin America
9.1 Latin America Human Somatotropin Market Size by Type
9.1.1 Latin America Human Somatotropin Sales by Type (2017-2028)
9.1.2 Latin America Human Somatotropin Revenue by Type (2017-2028)
9.2 Latin America Human Somatotropin Market Size by Application
9.2.1 Latin America Human Somatotropin Sales by Application (2017-2028)
9.2.2 Latin America Human Somatotropin Revenue by Application (2017-2028)
9.3 Latin America Human Somatotropin Market Size by Country
9.3.1 Latin America Human Somatotropin Sales by Country (2017-2028)
9.3.2 Latin America Human Somatotropin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Somatotropin Market Size by Type
10.1.1 Middle East and Africa Human Somatotropin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Somatotropin Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Somatotropin Market Size by Application
10.2.1 Middle East and Africa Human Somatotropin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Somatotropin Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Somatotropin Market Size by Country
10.3.1 Middle East and Africa Human Somatotropin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Somatotropin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Merck Serono
11.4.1 Merck Serono Corporation Information
11.4.2 Merck Serono Overview
11.4.3 Merck Serono Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck Serono Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Serono Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Corporation Information
11.5.2 F. Hoffmann-La Roche Overview
11.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffmann-La Roche Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Ferring Pharmaceuticals
11.6.1 Ferring Pharmaceuticals Corporation Information
11.6.2 Ferring Pharmaceuticals Overview
11.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ferring Pharmaceuticals Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ferring Pharmaceuticals Recent Developments
11.7 GeneScience Pharmaceuticals
11.7.1 GeneScience Pharmaceuticals Corporation Information
11.7.2 GeneScience Pharmaceuticals Overview
11.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GeneScience Pharmaceuticals Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GeneScience Pharmaceuticals Recent Developments
11.8 Ipsen
11.8.1 Ipsen Corporation Information
11.8.2 Ipsen Overview
11.8.3 Ipsen Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ipsen Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ipsen Recent Developments
11.9 LG Life Sciences
11.9.1 LG Life Sciences Corporation Information
11.9.2 LG Life Sciences Overview
11.9.3 LG Life Sciences Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 LG Life Sciences Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 LG Life Sciences Recent Developments
11.10 Sandoz International
11.10.1 Sandoz International Corporation Information
11.10.2 Sandoz International Overview
11.10.3 Sandoz International Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sandoz International Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sandoz International Recent Developments
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Corporation Information
11.11.2 Anhui Anke Biotechnology Overview
11.11.3 Anhui Anke Biotechnology Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Anhui Anke Biotechnology Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Anhui Anke Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Somatotropin Industry Chain Analysis
12.2 Human Somatotropin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Somatotropin Production Mode & Process
12.4 Human Somatotropin Sales and Marketing
12.4.1 Human Somatotropin Sales Channels
12.4.2 Human Somatotropin Distributors
12.5 Human Somatotropin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Somatotropin Industry Trends
13.2 Human Somatotropin Market Drivers
13.3 Human Somatotropin Market Challenges
13.4 Human Somatotropin Market Restraints
14 Key Findings in The Global Human Somatotropin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer